Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with Cirrhosis
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Although the prognosis is known to be poor in cirrhosis patients associated with sarcopenia, the relationships among skeletal muscle, visceral fat, and the liver have not yet been thoroughly investigated. Therefore, the prognosis and its associations with body composition and the severity of liver disease were examined in patients with cirrhosis. METHODS: The skeletal muscle mass and visceral fat area were measured in 161 patients with cirrhosis, the effects of body composition on the prognosis were analyzed, and any factors that contribute to changes in body composition were assessed. RESULTS: During the mean observation period of 1,005 days, 73 patients died. Patients with sarcopenia or sarcopenic obesity had a poor prognosis, and this difference was pronounced in the subset of patients classified as Child-Pugh class A. A decreased skeletal muscle mass was strongly correlated with decreased serum albumin levels. Sarcopenia is a common feature of advanced cirrhosis, and transitions were observed from normal body composition to sarcopenia and from obese to sarcopenic obesity. CONCLUSION: The body composition is a prognostic factor for cirrhosis, and a better body composition may be advantageous for obtaining a long-term survival in patients with cirrhosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051 · cited 1×
“7 kg/m(2) in women using the appendicular skeletal muscle mass (20).”
MethodBioelectrical impedance analysis—part II: utilization in clinical practice
Kyle, U. G., Bosaeus, I., De Lorenzo, A. D., Deurenberg, P., Elia, M., Manuel Gómez, J., Lilienthal Heitmann, B., Kent-Smith, L., Melchior, J.-C., Pirlich, M., et al. (2004) · Clinical Nutrition · doi:10.1016/j.clnu.2004.09.012 · Cited by 2,350 · cited 1×
“However, caution is necessary in diseases that lead to an increased amount of body fluids, such as cirrhosis, since such measurements may be overestimated (21).”
BackgroundSurvival advantages of obesity in dialysis patients
Kalantar-Zadeh, K., Abbott, K. C., Salahudeen, A. K., Kilpatrick, R. D., & Horwich, T. B. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.3.543 · Cited by 610
Lim, S., Kim, J. H., Yoon, J. W., Kang, S. M., Choi, S. H., Park, Y. J., Kim, K. W., Lim, J. Y., Park, K. S., & Jang, H. C. (2010) · Diabetes Care · doi:10.2337/dc10-0107 · Cited by 588 · cited 1×
“On the other hand, although it is a well-known fact that visceral obesity causes insulin resistance and leads to a high risk of developing cancer or cardiovascular events, it is also reported that sarcopenic obesity (the coexistence of sarcopenia and visceral obesity) is an advanced metabolic disorder showing severe m…”
BackgroundSarcopenic obesity is closely associated with metabolic syndrome
Lu, C.-W., Yang, K.-C., Chang, H.-H., Lee, L.-T., Chen, C.-Y., & Huang, K.-C. (2013) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2012.02.003 · Cited by 198
Cited by
Lai, J. C., Tandon, P., Bernal, W., Tapper, E. B., Ekong, U., Dasarathy, S., & Carey, E. J. (2021) · Hepatology · doi:10.1002/hep.32049 · Cited by 742
Sarcopenia from mechanism to diagnosis and treatment in liver disease
Dasarathy, S., & Merli, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.040 · Cited by 608
Kim, G., Kang, S. H., Kim, M. Y., & Baik, S. K. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186990 · Cited by 369
Implications of low muscle mass across the continuum of care: a narrative review
Prado, C. M., Purcell, S. A., Alish, C., Pereira, S. L., Deutz, N. E., Heyland, D. K., Goodpaster, B. H., Tappenden, K. A., & Heymsfield, S. B. (2018) · Annals of Medicine · doi:10.1080/07853890.2018.1511918 · Cited by 286
“In these individuals, low muscle mass was associated with worse albumin levels [139], Child-Pugh scores [139], physical function [140] (correlation only) and shorter survival [138,141,142].”
BackgroundZhang, X., Xie, X., Dou, Q., Liu, C., Zhang, W., Yang, Y., Deng, R., & Cheng, A. S. K. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1195-y · Cited by 209
“One study used the midarm muscle circumference (MAMC)-based definition of SO [24], eight used the SMM-based definition [15, 24, 25, 27, 28], three used the muscle strength (MS)-based definition [17, 18, 22], three used the appendicular lean mass (ALM)/BMI-based definition [16, 23], and eight used the SMI-based definit…”
BackgroundMethodInfluential
Metadata
- Authors
- Hara, N., Iwasa, M., Sugimoto, R., Mifuji-Moroka, R., Yoshikawa, K., Terasaka, E., Hattori, A., Ishidome, M., Kobayashi, Y., Hasegawa, H., Iwata, K., & Takei, Y.
- Venue
- Internal Medicine
- Published
- 2016
- Volume
- 55
- Issue
- 8
- Pages
- 863-870
- ISSN
- 0918-2918 (ISSN-L)
- 1349-7235
- OpenAlex
- W2339114191
- Cited by
- 113
- References
- 5
- FWCI
- 10.04
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with Cirrhosis. https://app.cochat.ai/papers/10.2169/internalmedicine.55.5676
- The paper
- Hara, N., Iwasa, M., Sugimoto, R., Mifuji-Moroka, R., Yoshikawa, K., Terasaka, E., Hattori, A., Ishidome, M., Kobayashi, Y., Hasegawa, H., Iwata, K., & Takei, Y. (2016). Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with Cirrhosis. Internal Medicine. https://doi.org/10.2169/internalmedicine.55.5676
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.